| Systematic (IUPAC) name | |
|---|---|
| (S)-(4-fluorophenyl)-(3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]piperidin-1-yl)methanone | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 11383075 |
| IUPHAR ligand | 1420 |
| ChemSpider | 9557988 |
| ChEMBL | CHEMBL381055 |
| Chemical data | |
| Formula | C20H17F2N3O2 |
| Mol. mass | 369.364 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
ADX-47273 is a drug used in scientific research which acts as a positive allosteric modulator selective for the metabotropic glutamate receptor subtype mGluR5.[1] It has nootropic and antipsychotic effects in animal studies,[2] and has been used as a lead compound to develop improved derivatives.[3]
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)